© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
557794 |
As an accredited 6-Bromo-4-Chloroquinoline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-4-Chloroquinoline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
6-Bromo-4-Chloroquinoline isn’t one of those chemicals you hear about in everyday conversation, but for chemists and pharmaceutical researchers, it’s a name that rings a bell. This quinoline derivative carries a bromine at the 6-position and a chlorine at the 4-position, creating a unique setup in the molecular structure. Unlike alternatives that may only carry a single halogen modification or sit within crowded patent spaces, this compound offers just the right degree of substitution for a spectrum of synthetic applications. I remember coming across it in the lab during a project on C–N bond formation—tasks that demand not just reactivity, but reproducibility. While some compounds offer limited solubility or unpredictable results, 6-Bromo-4-Chloroquinoline has shown reliable performance batch after batch.
This isn’t just a building block for theoretical work. The pharmaceutical industry prizes quinoline derivatives for their range of pharmacological activities, from anti-malarial to anti-inflammatory prospects. The bromo and chloro positions on this molecule open up predictable pathways for cross-coupling reactions, like Suzuki-Miyaura and Buchwald-Hartwig, that drive the creation of new molecular scaffolds. Medicinal chemists often talk about the frustration of seeing products stall in intermediate states when working with less reactive molecules. One strong point for 6-Bromo-4-Chloroquinoline: its halogenation pattern boosts both electronic and steric effects, which translates to easier downstream functionalization, less time spent on purification, and a higher success rate in multi-step syntheses.
People in the lab rarely care about bells and whistles; they want consistency and clarity. The compound typically appears as an off-white to light-yellow crystalline powder. With a molecular weight of 258.49 g/mol and a melting point often found between 70°C and 74°C, it stays solid under typical storage conditions. It dissolves best in organic solvents that already see wide use, such as dichloromethane and dimethylformamide, so no one has to scramble to source specialty reagents.
I’ve found the purity levels that reputable vendors provide—often checked by HPLC or NMR—help cut down repeat testing, saving both time and resources. Impurities can wreck a reaction, especially when pushing for gram scale, so having a compound that meets high specifications isn’t just useful—it’s essential for reproducibility. This compound usually fits the bill.
Some might wonder why not just use a straight chloroquinoline or bromoquinoline. The answer comes back to versatility. Each small change in a molecule’s structure tweaks its reactivity. From my experience, especially in exploring new kinase inhibitor scaffolds, that dual-halogen approach makes all the difference. Other halogenated quinolines don’t offer the same balance of stability and reactivity. Mono-halogen derivatives sometimes sit stubbornly in test tubes, failing to participate in cross-coupling reactions. Double-substituted products, with substitutions at the 6 and 4 positions, strike the right balance: steric hindrance is minimal, reactivity is high, and stability during storage remains solid.
Researchers who push the frontiers of heterocyclic chemistry have noticed this difference. The literature backs it up—multiple peer-reviewed studies use this compound as a key starting point for new antimalarials and kinase inhibitors. The dual-halogen motif turns out to be not just a minor tweak, but a genuine advantage when the goal is to access a broad range of derivatives efficiently.
Working with chemicals has taught me that easy wins can slip away fast without proper handling. 6-Bromo-4-Chloroquinoline, compared to many organometallic precursors, handles fairly easily. It stores well in sealed containers, in cool and dry spots, without crystal degradation or scary exothermic surprises. Of course, standard safe laboratory practices still apply: gloves, eye protection, and adequate ventilation remain non-negotiable. But I appreciate not having to worry about reactivity with atmospheric moisture or light-driven decomposition, both of which have plagued other quinoline derivatives in past projects.
Commercial adoption of any fine chemical depends on availability and ease of scale-up. My experience with 6-Bromo-4-Chloroquinoline—from test tubes to kilolab runs—shows that it maintains quality as the batches get larger. Technicians don’t have to tweak every parameter; standard equipment and straightforward batch processing work. Compared to quinolines with more exotic substitutions that often jam up filtration systems or require elaborate precautions, this compound flows smoothly through the workup process. It cuts down on the waste and unpredictability that can slow scale-up. Firms working in contract research settings benefit from that kind of reliability every day.
One thing I’ve seen in the literature and from vendor communications: the supply chain for this kind of specialized halogenated quinoline has matured in recent years. You don’t see the scarcity or price spikes the way you might with more niche building blocks. Consistency of supply removes a major roadblock for process developers, especially those looking to move from small discovery batches to larger pilot lots.
Ask any medicinal chemist and they’ll tell you that starting points matter. Getting stuck with sluggish or uncooperative intermediates adds weeks to a project timeline. 6-Bromo-4-Chloroquinoline, by presenting well-placed leaving groups, enables chemists to dial in substitutions that matter for activity. I’ve seen research teams use it to build out libraries of analogs, exploring new territory in antimalarial, antibacterial, and anticancer drug leads. Each change at the 6 or 4 position can translate to drastic differences in biological activity, and the ease with which those changes can be made makes this compound valuable.
Its predictability and straightforward chemistry also mean that students in undergraduate and graduate research labs aren’t left floundering. They get real, tangible results, and ultimately move faster from concept to publication. The compound doesn’t just sit in a bottle on a shelf—it drives projects forward.
Materials scientists have caught on as well. Extended quinoline cores, like those derived from 6-Bromo-4-Chloroquinoline, play roles in optoelectronic applications and organic semiconductors. The dual halogen positions make for handy reactive handles during polymer synthesis, supporting both innovative materials research and the need for scalable, affordable feedstocks.
At some point, researchers face a decision: which quinoline derivative fits the job? Traditional 4-chloroquinoline offers a decent start for basic substitution, but lacks the second halogen for more advanced cross-coupling routes. If you go with just 6-bromoquinoline, you miss easy access to derivatives with dual modifications—often a must in pharmaceuticals where tiny tweaks can yield big improvements in potency or selectivity.
Even among multi-halogenated options, 6-Bromo-4-Chloroquinoline stands out by not lumping bulky groups together or scattering activity-poor regions across the molecule. The arrangement at 4 and 6 proves nearly ideal for many coupling reactions. Colleagues who have worked with more heavily substituted quinolines sometimes run into steric congestion or reduced yields. Here, the efficient packing and electron distribution in the structure tend to give smoother, higher-yielding transformations.
Chemical cost matters as well. Bulky, poly-substituted quinolines drive costs up—not only at procurement but throughout the synthetic chain, with higher solvent requirements, more steps for purification, and greater waste generation. I’ve noticed that working with 6-Bromo-4-Chloroquinoline helps labs stick to budget without compromising quality or project scope.
Years in the lab have made one thing clear: not all sources of specialty chemicals treat purity and batch-to-batch consistency with equal seriousness. For this compound, global suppliers have recognized the demands of today’s researchers and stepped up with improved manufacturing protocols. High-performance liquid chromatography and NMR checks give peace of mind. Buyers in both academia and industry regularly push for certificates of analysis, and most quality suppliers now deliver those as a matter of course.
Turnaround times used to stretch out for niche heterocycles, but logistical improvements now mean that even small research labs can access multi-gram lots without waiting weeks. Cold-chain shipping or climate-controlled warehouses aren’t typically necessary. That practicality gives medium-sized labs and startups a better shot at keeping pace with larger competitors.
Pharmaceutical discovery has shifted focus over the last decade, demanding scaffold diversity and functional group flexibility. 6-Bromo-4-Chloroquinoline keeps showing up where teams are racing to produce new kinase inhibitors or anti-infective agents with improved selectivity. It offers organic chemists a reliable template where one or both halogen positions can be swapped out for a broad range of groups, using modern cross-coupling catalysis under mild conditions.
Some high-profile patents and publications highlight its use as a springboard for second- and third-generation drug analogs. In personal experience, its presence in the starting lineup lets teams perform “late-stage functionalization”—great if you want to tweak properties without reworking your entire synthetic pathway. This saves both money and time. Researchers pressing toward IND-enabling studies or scale-up for clinical candidates can appreciate the luxury of such modularity.
Academic labs benefit by training students and postdocs on modern synthetic techniques—using a real, practical molecule instead of fighting with slow or unreliable reagents. Education gets a boost since results match expectations and reproducibility comes built in.
Research pushes boundaries. Every year, new synthetic protocols, analytical techniques, and automation tools show up in the literature. 6-Bromo-4-Chloroquinoline adapts nicely: its robust nature and broad applicability invite innovation across both established and emerging areas. As green chemistry principles gain ground, researchers want to minimize solvent use, cut out unnecessary steps, and avoid hazardous reagents. The dual halogen handle on this molecule means reactions proceed efficiently, often under mild, less toxic conditions.
With computational chemistry and cheminformatics growing in importance, there’s always a need for reliable, high-purity compounds that model well in silico before labs spend resources on synthesis. 6-Bromo-4-Chloroquinoline’s straightforward structure and reactivity profile make it a recurring feature in virtual screens and AI-driven drug design workflows.
Its adaptability carries over into combinatorial chemistry, too. Automated platforms for library synthesis run into fewer hiccups using compounds like this, avoiding issues with stability, solubility, or stubborn side reactions. This keeps the pipeline moving and innovation front and center.
I’ve worked with plenty of quinoline derivatives over the years, and not all have left a positive mark. Some clog up chromatography columns, some produce intractable emulsions, and others just sit in reagent drawers gathering dust. 6-Bromo-4-Chloroquinoline isn’t that kind of reagent. Its predictability matters as timelines tighten and budgets get squeezed. New research directions demand robust, versatile building blocks, and this one fits the bill—helping unite the demands of specialty synthesis with realistic constraints of time, money, and space.
There are always hurdles in drug discovery, materials science, or method development. Having reliable, well-characterized compounds takes away some of the guesswork, freeing up focus for innovation rather than damage control. In short, it belongs in any toolkit where creativity, efficiency, and results matter.
No compound comes without drawbacks. 6-Bromo-4-Chloroquinoline, like many halogenated aromatics, can raise disposal or environmental questions if not managed properly. Industry and academia must partner to ensure that waste handling stays up to standard and that protocols follow best practices for safety and sustainability. Green chemistry approaches—recycling solvents, capturing halogen waste, using catalytic processes—should remain top-of-mind for anyone working with it.
Screening suppliers for responsible manufacturing and transparent sourcing helps ensure that ethical and safety standards get met. Education plays a part here as well: training chemists, students, and technicians on sustainable practices and responsible use makes for a healthier, safer future for the field.
Research funding increasingly tracks not just discoveries, but process improvements and risk mitigation. By choosing reliable, well-characterized compounds, labs position themselves to meet both scientific and regulatory goals. In the end, 6-Bromo-4-Chloroquinoline proves valuable not just for what it builds, but for how it supports progress—practically and responsibly.
